Survival of total knee arthroplasty in patients with Parkinson's disease: a registry study.
Survival of total knee arthroplasty in patients with Parkinson's disease: a registry study.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Bologna, IT · Author affiliation
1st Orthopardic Department, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy. alessandro.panciera@ior.it.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
PURPOSE: This study compared the demographics and outcomes of patients with Parkinson's disease (PD) undergoing total knee arthroplasty (TKA) to those without PD. Additionally, it aimed to assess the impact of implant design on TKA survival in PD patients. METHODS: Using data from the Emilia Romagna Registry of Orthopedic Prosthetic Implants, 551 TKA procedures in patients with PD were identified and compared to 52,022 TKAs in patients without PD. Kaplan-Meier survivorship analysis was used to compare implant survival, with revision surgery as the endpoint. Cox multivariate analysis was performed to assess the influence of age, gender, PD diagnosis, and implant design on implant failure. RESULTS: The average age of PD patients was 72.2 years, with 66.2% being female. Implant survival was significantly lower in the PD group compared to the control group (p < 0.001). At 13 years, the survival rate was 88.8% in the PD group and 94.3% in the control group. PD patients had a 2.7 times higher risk of implant failure after adjusting for age and gender. Constrained implant designs were associated with a 1.7 times higher risk of failure compared to non-constrained designs in PD patients. CONCLUSION: PD negatively affects implant survival in patients undergoing TKA. Careful consideration should be given to patient selection and implant design in this patient population.